R. Briesewitz

发表

Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.

Anne-Marie Duchemin, M. Caligiuri, D. Kusewitt, 2007, Blood.

activity or acquired resistance in acute myeloid leukemia

M. Caligiuri, D. Kusewitt, Lisheng Wang, 2007 .

Pharmacologic inhibition of CDK 4 / 6 : mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia

M. Caligiuri, D. Kusewitt, Lisheng Wang, 2007 .

Inhibition of Ras-Effector Interaction by Cyclic Peptides.

M. Villalona-Calero, R. Briesewitz, D. Pei, 2013, MedChemComm.

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

Torsten Haferlach, Stefano Volinia, Carlo M. Croce, 2008, Proceedings of the National Academy of Sciences.

The role of the I domain in ligand binding of the human integrin alpha 1 beta 1.

R. Briesewitz, E. Marcantonio, I. Bank, 1994, The Journal of biological chemistry.

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

M. Caligiuri, J. Griffin, R. Briesewitz, 2003, Proceedings of the National Academy of Sciences of the United States of America.

A bifunctional molecule that displays context-dependent cellular activity.

K. Haldar, T. Wandless, R. Briesewitz, 2003, Journal of the American Chemical Society.

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

M. Caligiuri, O. Abdel-Wahab, R. Levine, 2013, Blood.

The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency.

L. Smilenov, R. Briesewitz, F. S. David, 1996, Molecular biology of the cell.

Assembly and Function of Integrin Receptors Is Dependent on Opposing a and f3 Cytoplasmic Domains

R. Briesewitz, E. Marcantonio, A. Kern, 2022 .

Cell adhesion to extracellular matrix regulates the life cycle of integrins.

R. Briesewitz, E. Scharf, R. Assoian, 1995, Molecular biology of the cell.

Expression of native and truncated forms of the human integrin alpha 1 subunit.

R. Briesewitz, E. Marcantonio, M. Epstein, 1993, The Journal of biological chemistry.

Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs.

R. Briesewitz, S. Jhiang, D. Pei, 2013, ACS chemical biology.

The Mll PTD and Flt3 ITD Double Knock-In Mouse Develops Acute Leukemia and Recapitulates Phenotypic, Molecular and Epigenetic Characteristics of the Counterpart Human Acute Myeloid Leukemia

M. Caligiuri, Yue-zhong Wu, D. Jarjoura, 2010 .

DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance

R. Briesewitz, L. Fisher, M. Oram, 1990, Journal of Bacteriology.

Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, Lisheng Wang, 2007, Blood.

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

M. Caligiuri, C. Bloomfield, J. Byrd, 2010, Cancer cell.

Sp1/NF κ B/HDAC/ miR-29b Regulatory Network in KIT-driven Myeloid Leukemia

M. Caligiuri, C. Bloomfield, J. Byrd, 2010 .

RET fusion genes in non-small-cell lung cancer.

M. Villalona-Calero, R. Briesewitz, B. Chao, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ligand-dependent and -independent integrin focal contact localization: the role of the alpha chain cytoplasmic domain.

R. Briesewitz, E. Marcantonio, A. Kern, 1993, Molecular biology of the cell.

Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment.

L. Smilenov, R. Briesewitz, E. Marcantonio, 1994, Molecular biology of the cell.

Calcineurin inhibitors and the generalization of the presenting protein strategy.

G. Crabtree, T. Wandless, R. Briesewitz, 2001, Advances in protein chemistry.

Inhibition of Ras signaling by blocking Ras-effector interactions with cyclic peptides.

Sarah R. Clippinger, Sarah R Clippinger, Punit Upadhyaya, 2015, Angewandte Chemie.

Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces.

G. Crabtree, T. Wandless, R. Briesewitz, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Assembly and function of integrin receptors is dependent on opposing alpha and beta cytoplasmic domains.

R. Briesewitz, E. Marcantonio, A. Kern, 1995, Molecular biology of the cell.

Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells.

M. Caligiuri, A. Ferketich, R. Briesewitz, 2009, Blood.

Gyrase Proteins and Implications for 4-Quinolone Action and Resistance

R. Briesewitz, L. Fisher, M. Oram, 2022 .

Engineering small molecule specificity in nearly identical cellular environments.

K. Stankunas, G. Crabtree, T. Wandless, 2007, Bioorganic & medicinal chemistry letters.

Creating diverse target-binding surfaces on FKBP12: synthesis and evaluation of a rapamycin analogue library.

Lisheng Wang, R. Briesewitz, Xiche Hu, 2011, ACS combinatorial science.

Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces.

T. Wandless, R. Briesewitz, G. T. Ray, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, Lisheng Wang, 2007, Blood.

Evidence of MicroRNA-29b and Sp1/NFκB-HDAC Regulatory Network for KIT Expression in KIT-Driven Acute Myeloid Leukemia (AML): Biologic and Therapeutic Implications.

M. Caligiuri, J. Byrd, Yue-zhong Wu, 2009 .